Geometric and dosimetric quality assurance using logfiles and a 3D helical diode detector for Dynamic WaveArc

PurposeTo conduct patient-specific geometric and dosimetric quality assurance (QA) for the Dynamic WaveArc (DWA) using logfiles and ArcCHECK (Sun Nuclear Inc., Melbourne, FL, USA).MethodsTwenty DWA plans, 10 for pituitary adenoma and 10 for prostate cancer, were created using RayStation version 4.7 (RaySearch Laboratories, Stockholm, Sweden). Root mean square errors (RMSEs) between the actual and planned values in the logfiles were evaluated. Next, the dose distributions were reconstructed based on the logfiles. The differences between dose-volumetric parameters in the reconstructed plans and those in the original plans were calculated. Finally, dose distributions were assessed using ArcCHECK. In addition, the reconstructed dose distributions were compared with planned ones.ResultsThe means of RMSEs for the gantry, O-ring, MLC position, and MU for all plans were 0.2°, 0.1°, 0.1 mm, and 0.4 MU, respectively. Absolute means of the change in PTV D_99% were 0.4 ± 0.4% and 0.1 ± 0.1% points between the original and reconstructed plans for pituitary adenoma and prostate cancer, respectively. The mean of the gamma passing rate (3%/3 mm) between the measured and planned dose distributions was 97.7%. In addition, that between the reconstructed and planned dose distributions was 99.6%.ConclusionsWe have demonstrated that the geometric accuracy and gamma passing rates were within AAPM 119 and 142 criteria during DWA. Dose differences in the dose-volumetric parameters using the logfile-based dose reconstruction method were also clinically acceptable in DWA.